CD19 CAR T-cells for Pediatric Relapsed Acute Lymphoblastic Leukemia with Active CNS Involvement: A Retrospective International Study

Investigators reported an international study of fifty-five children and adolescents who received CAR T-cell therapy for relapsed B-cell precursor acute lymphoblastic leukemia with central nervous system involvement at the time of referral.